AMSA Pharm-free Scorecard 2008
D University of Maryland School of Medicine
City: Baltimore State: MD
Commentary:
Few of the evaluated conflicts of interest domains were addressed by the University of Maryland School of Medicine policy. The policy is weakest in the areas of professional educational activities and funding for trainees, which are unregulated according to the provided policies. University of Maryland School of Medicine is progressive in that it requires approval for all outside professional activities, but the school has not taken steps to outline unambiguously which types of outside professional activities are permitted and which are not.

Gifts & Meals 1 A ban on solicitation and acceptance of gifts and honoraria was referenced but not provided.
Consulting relationships 2 Faculty at the School of Medicine are required to have outside professional activities pre-approved.
Industry-funded speaking relationships 2 Faculty are required to have outside professional activities pre-approved.
Disclosure 2 The School of Medicine requires internal disclosure of outside professional activities.
Pharmaceutical samples 1 The School of Medicine does have a supplier’s policy, but does not restrict the use of samples as a marketing tool in any significant way.
Purchasing & Formularies 2 Members of the pharmacy and therapeutics committee are required to disclose all financial relationships under the provision for general disclosure.
Site Access 2 Industry representatives must have a scheduled meeting in order to be on School of Medicine property.
On-campus Education 1 No policy, or policy not provided.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 1 No policy, or policy not provided.
Industry Support for Scholarships & Funds for Trainees 1 No policy, or policy not provided.
Medical school curriculum 1 The School of Medicine indicates that industry marketing and conflicts of interest are covered in its curriculum, but did not provide any examples or further details on the curriculum.
Do the policies specify an oversight mechanism? No No established body for oversight. (Policy only lists Board of Regents as recipient of reports for disclosure.)
Are there explicit sanctions for noncompliance? No Apart from penalties that may be associated with the state disclosure law, no specific sanctions for non-compliance with School of Medicine policies are given. 
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)